Ginkgo Bioworks EBITDA vs. Return On Asset

DNA Stock  USD 7.18  0.59  8.95%   
Based on Ginkgo Bioworks' profitability indicators, Ginkgo Bioworks Holdings may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess Ginkgo Bioworks' ability to earn profits and add value for shareholders.
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
-821.3 M
Current Value
-862.4 M
Quarterly Volatility
676.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
As of November 25, 2024, Price To Sales Ratio is expected to decline to 12.41. In addition to that, Days Sales Outstanding is expected to decline to 43.77. At present, Ginkgo Bioworks' Accumulated Other Comprehensive Income is projected to decrease significantly based on the last few years of reporting. The current year's Net Interest Income is expected to grow to about 58 M, whereas Operating Income is forecasted to decline to (907.6 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.760.7852
Sufficiently Down
Slightly volatile
For Ginkgo Bioworks profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Ginkgo Bioworks to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Ginkgo Bioworks Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Ginkgo Bioworks's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Ginkgo Bioworks Holdings over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. If investors know Ginkgo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ginkgo Bioworks listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(12.89)
Revenue Per Share
4.291
Quarterly Revenue Growth
0.606
Return On Assets
(0.21)
Return On Equity
(0.64)
The market value of Ginkgo Bioworks Holdings is measured differently than its book value, which is the value of Ginkgo that is recorded on the company's balance sheet. Investors also form their own opinion of Ginkgo Bioworks' value that differs from its market value or its book value, called intrinsic value, which is Ginkgo Bioworks' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ginkgo Bioworks' market value can be influenced by many factors that don't directly affect Ginkgo Bioworks' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ginkgo Bioworks' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ginkgo Bioworks is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ginkgo Bioworks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Ginkgo Bioworks Holdings Return On Asset vs. EBITDA Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Ginkgo Bioworks's current stock value. Our valuation model uses many indicators to compare Ginkgo Bioworks value to that of its competitors to determine the firm's financial worth.
Ginkgo Bioworks Holdings is rated below average in ebitda category among its peers. It is rated # 2 in return on asset category among its peers . At present, Ginkgo Bioworks' EBITDA is projected to decrease significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ginkgo Bioworks' earnings, one of the primary drivers of an investment's value.

Ginkgo Return On Asset vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Ginkgo Bioworks

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(821.29 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Ginkgo Bioworks

Return On Asset

 = 

Net Income

Total Assets

 = 
-0.21
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.

Ginkgo Return On Asset Comparison

Ginkgo Bioworks is currently under evaluation in return on asset category among its peers.

Ginkgo Bioworks Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Ginkgo Bioworks, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Ginkgo Bioworks will eventually generate negative long term returns. The profitability progress is the general direction of Ginkgo Bioworks' change in net profit over the period of time. It can combine multiple indicators of Ginkgo Bioworks, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income1.5 M1.6 M
Net Interest Income55.2 M58 M
Interest Income57.2 M60.1 M
Operating Income-864.4 M-907.6 M
Net Loss-854.3 M-897 M
Income Before Tax-892.9 M-937.6 M
Total Other Income Expense Net-28.5 M-27.1 M
Net Loss-1.9 B-1.8 B
Net Loss-892.9 M-937.5 M
Income Tax Expense-71 K-74.5 K
Non Operating Income Net Other78.8 M70 M
Change To Netincome2.1 B2.2 B
Net Loss(18.37)(19.29)
Income Quality 0.33  0.39 
Net Income Per E B T 1.00  1.10 

Ginkgo Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Ginkgo Bioworks. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Ginkgo Bioworks position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Ginkgo Bioworks' important profitability drivers and their relationship over time.

Use Ginkgo Bioworks in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ginkgo Bioworks position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ginkgo Bioworks will appreciate offsetting losses from the drop in the long position's value.

Ginkgo Bioworks Pair Trading

Ginkgo Bioworks Holdings Pair Trading Analysis

The ability to find closely correlated positions to Ginkgo Bioworks could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ginkgo Bioworks when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ginkgo Bioworks - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ginkgo Bioworks Holdings to buy it.
The correlation of Ginkgo Bioworks is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ginkgo Bioworks moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ginkgo Bioworks Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ginkgo Bioworks can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Ginkgo Bioworks position

In addition to having Ginkgo Bioworks in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Rentals Thematic Idea Now

Rentals
Rentals Theme
Companies providing rental and leasing services to public and business. The Rentals theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Rentals Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Ginkgo Bioworks Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ginkgo Bioworks' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ginkgo Bioworks Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ginkgo Bioworks Holdings Stock:
Check out Investing Opportunities.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
To fully project Ginkgo Bioworks' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Ginkgo Bioworks Holdings at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Ginkgo Bioworks' income statement, its balance sheet, and the statement of cash flows.
Potential Ginkgo Bioworks investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Ginkgo Bioworks investors may work on each financial statement separately, they are all related. The changes in Ginkgo Bioworks's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ginkgo Bioworks's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.